Alembic gets US FDA nod for Bromfenac Ophthalmic Solution, 0.07 per cent EP News Bureau Jul 9, 2024 The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolensa Ophthalmic Solution, 0.07 per…
Alembic Pharma received eight USFDA approvals in Q3FY24 EP News Bureau Jan 2, 2024 The company has received five final approvals and three tentative approvals
Lupin gets US FDA nod for Bromfenac Ophthalmic Solution, 0.09%; Metoprolol Succinate ER Tablets USP EP News Bureau Aug 16, 2023 Both products will be manufactured at Lupin’s Pithampur facility in India
Alembic Pharma gets US FDA nod for ophthalmic solution Press Trust of India Jun 24, 2019 The approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 per cent,…